drugset / Trial / NCT00497458

Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects

NCT00497458

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate whether increasing blood levels of androgen can reduce some of the side-effects of anti-estrogen therapy (Arimidex)

Timeline

Start
2007-07
Primary completion
2009-04
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Testosterone Small molecule 40 mg
Comparator Testosterone Small molecule 80 mg